These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10526956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. NV1FGF, a pCOR plasmid-based angiogenic gene therapy for the treatment of intermittent claudication and critical limb ischemia.
    Maulik N.
    Curr Opin Investig Drugs; 2009 Mar; 10(3):259-68. PubMed ID: 19333884
    [Abstract] [Full Text] [Related]

  • 26. Angiogenesis in the human heart: gene and cell therapy.
    Tirziu D, Simons M.
    Angiogenesis; 2005 Mar; 8(3):241-51. PubMed ID: 16308736
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Angiogenesis (clinical trials).
    Laham R.
    Can J Cardiol; 2001 May; 17 Suppl A():29A-32A. PubMed ID: 11381293
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH.
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [Abstract] [Full Text] [Related]

  • 31. Angiogenesis: a "breakthrough" technology in cardiovascular medicine.
    Isner JM.
    J Invasive Cardiol; 2000 Feb; 12 Suppl A():14A-7A. PubMed ID: 10731291
    [Abstract] [Full Text] [Related]

  • 32. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
    Dai Q, Huang J, Klitzman B, Dong C, Goldschmidt-Clermont PJ, March KL, Rokovich J, Johnstone B, Rebar EJ, Spratt SK, Case CC, Kontos CD, Annex BH.
    Circulation; 2004 Oct 19; 110(16):2467-75. PubMed ID: 15477407
    [Abstract] [Full Text] [Related]

  • 33. VEGF gene transfer for diabetic neuropathy.
    Isner JM, Ropper A, Hirst K.
    Hum Gene Ther; 2001 Aug 10; 12(12):1593-4. PubMed ID: 11529248
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Angiogenic and antiangiogenic gene therapy.
    Malecki M, Kolsut P, Proczka R.
    Gene Ther; 2005 Oct 10; 12 Suppl 1():S159-69. PubMed ID: 16231050
    [Abstract] [Full Text] [Related]

  • 36. Angiogenesis therapy in ischemic disease.
    Silvestre JS, Lévy BI.
    Arch Mal Coeur Vaiss; 2002 Mar 10; 95(3):189-96. PubMed ID: 11998334
    [Abstract] [Full Text] [Related]

  • 37. Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase.
    Hisaka Y, Ieda M, Nakamura T, Kosai K, Ogawa S, Fukuda K.
    J Am Coll Cardiol; 2004 May 19; 43(10):1915-22. PubMed ID: 15145121
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. combination of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) to improve angiogenic gene therapy.
    Bouïs D, Boelens MC, Peters E, Koolwijk P, Stob G, Kema IP, Klinkenberg M, Mulder NH, Hospers GA.
    Angiogenesis; 2003 May 19; 6(3):185-92. PubMed ID: 15041794
    [Abstract] [Full Text] [Related]

  • 40. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.
    Su H, Lu R, Kan YW.
    Proc Natl Acad Sci U S A; 2000 Dec 05; 97(25):13801-6. PubMed ID: 11095751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.